✦ LIBER ✦

Response to pantoprazole is an effective diagnostic test for gastro-esophageal reflux disease: Results of a randomised double-blinded placebo-controlled pilot study

✍ Scribed by PM Neville; P. Moayyedi; A Edwards

Book ID: 118521588
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 171 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(98)80983-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: relief of upp

Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease

✍ Thomas, E.; Wade, A.; Crawford, G.; Jenner, B.; Levinson, N.; Wilkinson, J. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Esomeprazole once daily for 6 months is

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

✍ David A Johnson; Stanley B Benjamin; Nimish B Vakil; Jay L Goldstein; Mark Lamet 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 269 KB

Ofatumumab, a human anti-CD20 monoclonal

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

✍ Mikkel Østergaard; Bo Baslund; William Rigby; Bernadette Rojkovich; Christian Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views